慢性肾脏病的检测与评估
多种指南推荐对糖尿病、高血压、心血管疾病史等高危人群至少每年筛查血清肌酐、尿白蛋白/肌酐比值和尿常规。持续升高的血清肌酐和白蛋白尿是诊断和预后标志,新指南将白蛋白尿纳入分类框架并明确随访频率和肾内科转诊指征。
要点
- 高危人群(糖尿病、高血压、心血管疾病史)应至少每年筛查血清肌酐、尿白蛋白/肌酐比值和尿常规。
- 持续升高的血清肌酐和白蛋白尿是慢性肾脏病的诊断和预后标志,较低水平白蛋白尿也与不良肾脏和心血管结局相关。
- 肾内科会诊指征包括eGFR<30 mL/min/1.73 m²、持续尿白蛋白/肌酐比值>300 mg/g或尿蛋白/肌酐比值>500 mg/g,或肾功能快速下降证据。
核心结论
- 慢性肾脏病可无症状进展至晚期,早期检测对及时启动干预至关重要,高危人群应定期筛查。
研究设计与样本
- 本文为综述,汇总慢性肾脏病检测与评估的相关指南和证据。
主要发现
- 持续升高的血清肌酐和白蛋白尿是诊断和预后标志,较低水平白蛋白尿也与不良肾脏和心血管结局相关。
- 血清胱抑素C是新型生物标志物,在怀疑血清肌酐估算的eGFR假性降低时最有用。
关键数值与推荐
- 多种指南推荐对高危患者(特别是糖尿病、高血压和心血管疾病史)至少每年筛查血清肌酐、尿白蛋白/肌酐比值和尿常规。
- USPSTF认为证据不足以评估一般人群筛查慢性肾脏病的利弊平衡,ACP推荐不筛查无症状且无危险因素的成人。
- 肾内科会诊指征:eGFR<30 mL/min/1.73 m²,持续尿白蛋白/肌酐比值>300 mg/g或尿蛋白/肌酐比值>500 mg/g,或肾功能快速下降证据。
临床怎么用
- 对糖尿病、高血压、心血管疾病史等高危患者至少每年检测血清肌酐、尿白蛋白/肌酐比值和尿常规。
- 怀疑血清肌酐估算eGFR假性降低时可检测血清胱抑素C。
- 根据新指南将白蛋白尿纳入慢性肾脏病分类,并据此确定随访频率和肾内科转诊。
局限性
- 本文为综述,未报告原始研究数据或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease affects 47 million people in the United States and is associated with significant health care costs, morbidity, and mortality. Because this disease can silently progress to advanced stages, early detection is critical for initiating timely interventions. Multiple guidelines recommend at least annual screening with serum creatinine, urine albumin/creatinine ratio, and urinalysis for patients with risk factors, particularly diabetes mellitus, hypertension, and a history of cardiovascular disease. The U.S. Preventive Services Task Force found insufficient evidence to assess the balance of benefits and harms of screening for chronic kidney disease in the general population, and the American College of Physicians recommends against screening asymptomatic adults without risk factors. Persistently elevated serum creatinine and albuminuria are diagnostic and prognostic hallmarks of chronic kidney disease. Lower levels of albuminuria are associated with adverse renal and cardiovascular outcomes. Serum cystatin C is a novel biomarker that is most useful when a false-positive decreased estimated glomerular filtration rate calculated from serum creatinine is suspected. New guidelines incorporate albuminuria into the classification framework for chronic kidney disease and elaborate on identification of the disease, the frequency of follow-up, and recommendations for nephrology referral. Nephrology consultation is indicated for patients with an estimated glomerular filtration rate less than 30 mL per minute per 1.73 m2, persistent urine albumin/creatinine ratio greater than 300 mg per g or urine protein/creatinine ratio greater than 500 mg per g, or if there is evidence of a rapid loss of kidney function. A multidisciplinary approach between primary care physicians, nephrologists, and other subspecialists for implementing early interventions, providing education, and planning for advanced renal disease is key for effective management.
引用
- Gaitonde DY, Cook DL, Rivera IM, et al. Chronic Kidney Disease: Detection and Evaluation. Am Fam Physician. 2017. PMID: 29431364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。